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were performed by Kirby-Bauer method, MIC determination by
automated system (Phoenix, BD) and E-test method (Biomerieux SA,
France) according CLSI standards. Preliminary phenotypic detection
was based on the boronic acid disk test, a simple phenotypic algorithm
employing three combined-disc tests consisting of meropenem alone
and with phenylboronic acid (PBA), EDTA, and both PBA and EDTA.
Genotypic confirmation for the presence of the bla-KPC gene by PCR
and molecular typing by PFGE.
Results: Of 12 cases of bacteremia, seven catheter related infections,
three surgical site infections, two lower respiratory tract infections, five
ventilator-associated pneumonia and two urinary tract infections were
identified. Twenty-three infections were recorded in ICU, four in
Surgical and four in Internal Medicine unit respectively. Ninteen out of
25 patients were mechanically ventilated, 21 had central venous
catheter and 25 urinary-bladder catheter. The crude mortality, 28 days
after the first positive culture, was 32%.
Multidrug resistance characterized the studied isolates with an MIC
range to meromenem £1 to (32, with colistin, gentamicin and
tigecycline being the most active agents. Boronic acid disk test was
able to differentiate 26 KPC, 3 MBL producers and two co-producers of
both carbapenemases. PCR confirmed that all 26 isolates produce KPC-
2 b-lactamases and belong to the same dominant genotype in Greece.
Conclusion: In Greek hospitals, carbapenem resistance among
Klebsiella pneumoniae clinical isolates, is alarming and poses a
unique challenge for clinical microbiologists and clinicians.
Continuation of antibiotic policy and proper infection control
practices and barriers to prevent further spread, is mandatory.
Boronic acid disk test provides a simple algorithm for phenotypic
detection of carbapenemase production and for the differentiation of
KPC and MBL enzymes
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Objectives: In Portugal, little is known on carbapenemase (CARB)-
producing Enterobacteriaceae. The aim of this study was to identify the
resistance mechanisms of Enterobacteriaceae isolates, identified at
hospital laboratories as carbapenem (CA) non-susceptible.
Methods: This study included 61 Enterobacteriaceae isolates (26
Klebsiella spp., 15 Escherichia coli, nine Enterobacter spp., six
Morganella morgannii, four Proteus mirabilis, one Serratia
marcescens), collected between April 2006 and September 2011 and
sent to the NIH-Lisbon for CA susceptibility confirmation.
Antimicrobial susceptibility of clinical isolates was performed by disk
diffusion method (CA-SFM). Clinical isolates showing synergism
between CA and boronic acid (BOR) (and/or clavulanic acid, CLAV) or
with EDTA were considered presumptively CARB-producers from
class A or Class B, respectively. PCR and sequencing were applied to
detect and identify CARB-encoding genes; the respective genetic
environment was revealed by sequencing using PCR mapping. Direct
transfer of the CA resistance phenotype was attempted by mating-out
assays. Antibiotics susceptibility (MIC) of transconjugants and
respective isolates were tested by microdilution.
Results: The majority of isolates were collected from the urine (57.4%)
of elderly ((65 years old) male patients (54.1%), admitted at the
emergency room/ambulatory (24.6%) and at internal medicine (18.0%)
wards. Among all isolates, 50.8% were nonsusceptible to at least one
CA, being 67.2% multidrug-resistant; 16 isolates showed synergy
between CA and BOR (and/or CLAV). Among those, five were KPC-3-
producers (four Klebsiella pneumoniae and one Enterobacter clocae),
collected in 2010 (2) and 2011 (3). The blaKPC-3 genes were
confirmed to be carried by plasmids. Genetic environment of blaKPC-3
gene revealed the presence of a Tn4401 transposon in all but one isolate
(E. cloacae), suggesting that this last gene was included in other
Tn4401-like isoform. We also detected a VIM-2-producing Klebsiella
oxytoca, collected in 2009, among the seven isolates that showed
synergy between imipinem and EDTA. No blaGES, blaNDM or
blaIMP were detected.
Conclusion: This study provides new data regarding the molecular
epidemiology of CARB-producing Enterobacteriaceae in Portugal.
Overall, our results emphasize the need of a concerted action to manage
CA use. This is supported by EARS-Net, which reported an increase in
CA nonsusceptibility of K. pneumoniae isolates from 0.72% in 2008 to
1.58% in 2010.
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Objectives: To compare the resistance of Escherichia coli isolates
from adults with complicated and uncomplicated community-acquired
urinary tract infections (CAUTIs) in Russia.
Methods: A total of 282 and 196 uropathogens from adults with signs of
complicated and uncomplicated CAUTI in 17 cities of Russia (Moscow,
St. Petersburg, Chelyabinsk, Irkutsk, Kazan, Krasnodar, Omsk, Rostov-
on-Don, Samara, Seversk, Smolensk, Surgut, Tomsk, Tyumen, Ufa,
Yakutsk, Yekaterinburg) were collected during 2010–2011. The MICs
for antibiotics (amikacin – AMK, amoxicillin/clavulanate – AMX/CLV,
ampicillin – AMP, cefotaxime – CTX, ceftazidime – CTZ, cefepime –
CFPM, ciprofloxacin – CPX, co-trimoxazole – TMP/SMX, ertapenem –
ERT, fosfomycin – FSF, gentamicin – GNT, imipenem – IPM,
nitrofurantoin – NTF) were determined by agar dilution and interpreted
according to the EUCAST criteria (2011).
Results: Among the identified microorganisms the most frequent were
Enterobacteriaceae members (225 isolates [79.8%] in the group of
complicated CAUTI and 160 isolates in the group of uncomplicated
CAUTI [81.6%]) out of which there were 173 (61.3%) and 129 (65.8%)
E. coli strains, respectively. Resistance rates of E. coli in both study
groups are summarized in the Table. A statistically significant
difference in resistance rates to ampicillin (37.9% and 53.1%;
p < 0.05), cefotaxime (2.3% and 13.8%; p < 0.05), ceftazidime (3.0%
and 13.8%; p < 0.05), cefepime (3.0% and 11.0%; p < 0.05), co-
trimoxazole (21.8% and 32.4%; p < 0.05) and ciprofloxacin (10.8%
and 27.7%; p < 0.05) was observed between the groups of adults with
uncomplicated CAUTIs and complicated CAUTIs, respectively. A
significant distinction in ESBL production rate (2.3% and 13.8%;
p < 0.05) was also noted. The changes in susceptibility to other drugs
were statistically non significant.
Conclusions: The resistance rates of E. coli to ampicillin, co-
trimoxazole, III-IV generation cephalosporins and ciprofloxacin were
significantly higher in the group of adults with complicated CAUTIs
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